| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
55,117 |
46,414 |
$5.61M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
40,121 |
34,548 |
$5.60M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,478 |
5,231 |
$2.90M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
10,618 |
7,984 |
$1.77M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,486 |
10,039 |
$1.44M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,934 |
3,812 |
$1.14M |
| 99201 |
|
8,000 |
6,257 |
$1.03M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,874 |
9,152 |
$1.03M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,862 |
4,956 |
$944K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,091 |
13,609 |
$900K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,332 |
1,296 |
$674K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,851 |
3,527 |
$541K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,586 |
6,028 |
$456K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,529 |
4,815 |
$416K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,329 |
1,304 |
$415K |
| 70498 |
|
786 |
774 |
$406K |
| 70496 |
|
748 |
736 |
$382K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,157 |
5,257 |
$376K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
778 |
769 |
$370K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,407 |
1,353 |
$369K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,807 |
6,275 |
$347K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,631 |
2,489 |
$342K |
| 80053 |
Comprehensive metabolic panel |
33,523 |
28,872 |
$304K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,991 |
1,926 |
$295K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
496 |
487 |
$265K |
| 71045 |
Radiologic examination, chest; single view |
10,272 |
9,516 |
$260K |
| 76830 |
Ultrasound, transvaginal |
1,620 |
1,566 |
$242K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,390 |
31,578 |
$239K |
| J3490 |
Unclassified drugs |
46,532 |
24,414 |
$238K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,804 |
1,277 |
$223K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,328 |
1,297 |
$216K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,527 |
1,345 |
$213K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,317 |
2,255 |
$212K |
| 93971 |
|
818 |
787 |
$209K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,430 |
1,287 |
$199K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
308 |
304 |
$190K |
| 71046 |
Radiologic examination, chest; 2 views |
4,325 |
4,211 |
$184K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
275 |
270 |
$169K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,635 |
1,362 |
$150K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,720 |
1,070 |
$135K |
| 59025 |
Fetal non-stress test |
2,642 |
1,217 |
$134K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
191 |
188 |
$122K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
6,605 |
3,218 |
$112K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12,780 |
8,710 |
$109K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
11,293 |
9,662 |
$100K |
| 82077 |
|
3,577 |
3,255 |
$99K |
| 84484 |
|
10,899 |
8,645 |
$91K |
| 97803 |
|
1,670 |
1,652 |
$89K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
811 |
795 |
$88K |
| 76770 |
|
483 |
468 |
$81K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
564 |
240 |
$79K |
| 76801 |
|
627 |
570 |
$79K |
| 96367 |
|
810 |
644 |
$78K |
| 83690 |
|
13,170 |
11,853 |
$76K |
| 73610 |
|
1,257 |
1,224 |
$75K |
| 73030 |
|
1,230 |
1,199 |
$75K |
| 83880 |
|
2,569 |
2,384 |
$73K |
| 73630 |
|
1,294 |
1,265 |
$72K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
463 |
274 |
$72K |
| 73130 |
|
1,210 |
1,173 |
$71K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,634 |
9,041 |
$70K |
| 80143 |
|
1,881 |
1,718 |
$63K |
| 0450 |
Emergency room services |
1,025 |
926 |
$62K |
| Z7502 |
|
1,623 |
1,587 |
$62K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
469 |
419 |
$62K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
543 |
539 |
$61K |
| 87040 |
|
5,700 |
3,437 |
$59K |
| 80179 |
|
1,858 |
1,700 |
$57K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,144 |
5,764 |
$54K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,551 |
4,229 |
$53K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,658 |
4,993 |
$52K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,556 |
1,479 |
$49K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,555 |
1,476 |
$48K |
| J7050 |
Infusion, normal saline solution, 250 cc |
7,354 |
5,149 |
$48K |
| 73110 |
|
730 |
705 |
$44K |
| 83605 |
|
4,755 |
3,722 |
$44K |
| 81003 |
|
19,360 |
17,600 |
$43K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,939 |
5,388 |
$41K |
| J2704 |
Injection, propofol, 10 mg |
4,313 |
3,621 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
931 |
878 |
$38K |
| 73564 |
|
651 |
632 |
$38K |
| 90715 |
|
788 |
783 |
$34K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,434 |
2,364 |
$33K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,340 |
1,266 |
$32K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,362 |
2,870 |
$31K |
| 72141 |
|
53 |
53 |
$29K |
| 73562 |
|
433 |
424 |
$27K |
| 71250 |
|
59 |
57 |
$26K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,745 |
3,333 |
$25K |
| 85379 |
|
2,606 |
2,522 |
$22K |
| J2060 |
Injection, lorazepam, 2 mg |
3,539 |
2,951 |
$22K |
| 85730 |
|
3,915 |
3,700 |
$21K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,647 |
2,361 |
$21K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,271 |
2,922 |
$20K |
| 83735 |
|
3,519 |
3,175 |
$19K |
| 87634 |
|
327 |
299 |
$19K |
| 81025 |
|
5,577 |
5,360 |
$19K |
| 85610 |
|
5,285 |
4,909 |
$18K |
| 70486 |
|
38 |
38 |
$18K |
| 73221 |
|
28 |
28 |
$17K |
| 96523 |
|
127 |
101 |
$17K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
13 |
$17K |
| 87186 |
|
1,816 |
1,669 |
$17K |
| 87077 |
|
1,864 |
1,666 |
$16K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,610 |
1,433 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,467 |
2,257 |
$15K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,498 |
2,367 |
$15K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,221 |
2,026 |
$14K |
| 59425 |
|
92 |
55 |
$14K |
| 87400 |
|
1,766 |
1,743 |
$14K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,542 |
1,251 |
$13K |
| 97802 |
|
159 |
157 |
$13K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,284 |
1,872 |
$13K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,257 |
1,089 |
$12K |
| 82805 |
|
530 |
429 |
$12K |
| 74018 |
|
289 |
267 |
$11K |
| 96402 |
|
275 |
223 |
$10K |
| 86900 |
|
3,468 |
2,652 |
$10K |
| 87430 |
|
923 |
913 |
$9K |
| 87149 |
|
77 |
74 |
$9K |
| 86901 |
|
3,173 |
2,688 |
$9K |
| 76870 |
|
67 |
67 |
$9K |
| J1756 |
Injection, iron sucrose, 1 mg |
543 |
93 |
$8K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
53 |
30 |
$8K |
| Z9725 |
|
194 |
189 |
$8K |
| 87081 |
|
976 |
953 |
$8K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
724 |
662 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
61 |
60 |
$8K |
| 82947 |
|
1,613 |
1,436 |
$8K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
12 |
$8K |
| 87631 |
|
46 |
46 |
$7K |
| 70491 |
|
13 |
13 |
$7K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,040 |
910 |
$7K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
519 |
469 |
$7K |
| 97750 |
|
52 |
24 |
$6K |
| 86850 |
|
2,183 |
2,028 |
$6K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
108 |
108 |
$6K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
561 |
500 |
$5K |
| 86140 |
|
1,320 |
1,207 |
$5K |
| 87420 |
|
1,539 |
1,408 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
420 |
293 |
$5K |
| 96415 |
|
46 |
26 |
$4K |
| 73502 |
|
62 |
62 |
$4K |
| 84145 |
|
223 |
211 |
$4K |
| 81001 |
|
1,128 |
1,093 |
$4K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
196 |
127 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
25 |
25 |
$4K |
| 72100 |
|
37 |
37 |
$3K |
| 72110 |
|
25 |
25 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
414 |
367 |
$3K |
| 84702 |
|
243 |
189 |
$3K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
29 |
29 |
$3K |
| 73140 |
|
71 |
71 |
$3K |
| 82247 |
|
786 |
579 |
$3K |
| 94729 |
|
25 |
25 |
$3K |
| 72050 |
|
25 |
24 |
$3K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
140 |
97 |
$3K |
| 85652 |
|
1,265 |
1,186 |
$3K |
| 94726 |
|
25 |
25 |
$2K |
| 88342 |
|
164 |
160 |
$2K |
| S0028 |
Injection, famotidine, 20 mg |
422 |
323 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
13 |
12 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
339 |
334 |
$2K |
| 99199 |
Unlisted special service, procedure or report |
26 |
24 |
$2K |
| J3480 |
Injection, potassium chloride, per 2 meq |
100 |
69 |
$2K |
| 87210 |
|
576 |
535 |
$2K |
| 73080 |
|
28 |
26 |
$2K |
| 83789 |
|
36 |
36 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
28 |
12 |
$2K |
| 51701 |
|
39 |
38 |
$2K |
| 12001 |
|
37 |
37 |
$1K |
| 82550 |
|
220 |
197 |
$1K |
| 84075 |
|
374 |
337 |
$1K |
| 84450 |
|
370 |
336 |
$1K |
| 82040 |
|
373 |
338 |
$1K |
| 94060 |
|
13 |
13 |
$1K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$1K |
| 99070 |
|
77 |
63 |
$1K |
| 85027 |
|
209 |
181 |
$1K |
| 84155 |
|
370 |
336 |
$921.57 |
| 84703 |
|
157 |
151 |
$882.34 |
| J3360 |
Injection, diazepam, up to 5 mg |
58 |
50 |
$864.67 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
89 |
85 |
$861.76 |
| 96368 |
|
18 |
16 |
$839.63 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
33 |
15 |
$806.36 |
| 73090 |
|
13 |
13 |
$694.54 |
| 29125 |
|
44 |
42 |
$669.71 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
235 |
111 |
$643.88 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
59 |
55 |
$643.53 |
| 12011 |
|
12 |
12 |
$593.19 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
43 |
41 |
$557.28 |
| 10060 |
|
13 |
13 |
$479.85 |
| 84439 |
|
76 |
75 |
$469.31 |
| 88304 |
|
40 |
40 |
$456.43 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
28 |
12 |
$456.22 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
76 |
71 |
$382.49 |
| 84132 |
|
111 |
100 |
$343.75 |
| 87088 |
|
37 |
37 |
$327.32 |
| 82248 |
|
84 |
70 |
$291.40 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
37 |
30 |
$290.19 |
| Z7610 |
|
25 |
12 |
$260.36 |
| J1940 |
Injection, furosemide, up to 20 mg |
46 |
36 |
$259.23 |
| 80178 |
|
53 |
49 |
$249.26 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
30 |
29 |
$242.16 |
| 87205 |
|
71 |
63 |
$238.10 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
22 |
19 |
$193.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
34 |
17 |
$168.97 |
| 87045 |
|
17 |
12 |
$158.08 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
17 |
12 |
$157.46 |
| 86592 |
|
32 |
27 |
$111.93 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
26 |
$111.50 |
| 82570 |
|
33 |
27 |
$108.14 |
| 84295 |
|
39 |
33 |
$98.35 |
| 86308 |
|
27 |
27 |
$96.93 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
508 |
454 |
$91.09 |
| 87070 |
|
14 |
13 |
$89.57 |
| 87046 |
|
34 |
12 |
$83.52 |
| 87147 |
|
20 |
12 |
$78.20 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
169 |
115 |
$61.60 |
| 84156 |
|
21 |
16 |
$50.76 |
| 87899 |
|
13 |
13 |
$50.70 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
281 |
271 |
$25.01 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
27 |
26 |
$12.34 |